Stempeutics Research, backed by Ranjan Pai’s Manipal Education and Medical Group (MEMG) has signed an agreement to raise ₹95 crore from Bengaluru-based Kemwell Biopharma, for global commercialization of its stem cell product Stempeucel.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
